MD3592F1 - Uterotonic preparation for the treatment of uterine bleeding in the case of uterine myoma - Google Patents
Uterotonic preparation for the treatment of uterine bleeding in the case of uterine myoma Download PDFInfo
- Publication number
- MD3592F1 MD3592F1 MDA20070302A MD20070302A MD3592F1 MD 3592 F1 MD3592 F1 MD 3592F1 MD A20070302 A MDA20070302 A MD A20070302A MD 20070302 A MD20070302 A MD 20070302A MD 3592 F1 MD3592 F1 MD 3592F1
- Authority
- MD
- Moldova
- Prior art keywords
- uterine
- preparation
- uterotonic
- treatment
- case
- Prior art date
Links
- 206010046788 Uterine haemorrhage Diseases 0.000 title abstract 2
- 206010046798 Uterine leiomyoma Diseases 0.000 title abstract 2
- 230000003191 uterotonic effect Effects 0.000 title abstract 2
- 230000002411 adverse Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000023597 hemostasis Effects 0.000 abstract 1
- CSYSULGPHGCBQD-UHFFFAOYSA-N s-ethylisothiouronium diethylphosphate Chemical compound CCSC(N)=N.CCOP(O)(=O)OCC CSYSULGPHGCBQD-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Inventia se refera la medicina, in special la farmacologie si ginecologie. Esenta inventiei constain utilizarea dietilfosfatului de S-etilizotiouroniu in calitate de preparat uterotonic pentru tratamentul hemoragiilor uterine in cazul miomului uterin. Rezultatul inventiei consta in aceea ca la utilizarea locala a acestui preparat medicamentos in88% cazuri se obtine o hemostaza completa intr-untermen redus si fara efecte adverse.The invention relates to medicine, in particular pharmacology and gynecology. The essence of the invention consists of the use of S-ethylisothiouronium diethyl phosphate as a uterotonic preparation for the treatment of uterine bleeding in the case of uterine myoma. The result of the invention consists in the fact that at the local use of this medicinal preparation in 88% cases a complete hemostasis is obtained in reduced untermen and without adverse effects.
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20070302A MD3592G2 (en) | 2007-11-06 | 2007-11-06 | Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma |
| EP08846478.9A EP2219447B1 (en) | 2007-11-06 | 2008-11-06 | S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders |
| CN200880123695.5A CN101917848B (en) | 2007-11-06 | 2008-11-06 | S-Alkylisothiourea Derivatives for the Treatment of Hypertonic Disorders |
| US12/741,759 US20100305210A1 (en) | 2007-11-06 | 2008-11-06 | S-alkylisothiouronium derivatives for treating abnormal uterine bleeding disorders |
| PCT/IL2008/001466 WO2009060451A2 (en) | 2007-11-06 | 2008-11-06 | S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders |
| UAA201006063A UA104847C2 (en) | 2007-11-06 | 2008-11-06 | S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders |
| EA201000732A EA030035B1 (en) | 2007-11-06 | 2008-11-06 | Use of s-ethylisothiouronium diethylphosphate for the manufacture of a medicament for treating a uterine hypercontractility disorder |
| IL205535A IL205535A (en) | 2007-11-06 | 2010-05-04 | S- alkylisothiouronium derivatives for treating uterine hypercontractility disorders |
| US16/944,137 US12011423B2 (en) | 2007-11-06 | 2020-07-30 | S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20070302A MD3592G2 (en) | 2007-11-06 | 2007-11-06 | Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3592F1 true MD3592F1 (en) | 2008-05-31 |
| MD3592G2 MD3592G2 (en) | 2008-12-31 |
Family
ID=39471731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20070302A MD3592G2 (en) | 2007-11-06 | 2007-11-06 | Uterotonic preparation for treating uterine hemorrhages in case of hysteromyoma |
Country Status (2)
| Country | Link |
|---|---|
| MD (1) | MD3592G2 (en) |
| UA (1) | UA104847C2 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD2323G2 (en) * | 2003-06-23 | 2004-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Use of S-ethyl isothiouronium bromide (isoturon) as uterotonic preparation for treatment of uterine hemorrhages in case of uterine myoma |
-
2007
- 2007-11-06 MD MDA20070302A patent/MD3592G2/en not_active IP Right Cessation
-
2008
- 2008-11-06 UA UAA201006063A patent/UA104847C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MD3592G2 (en) | 2008-12-31 |
| UA104847C2 (en) | 2014-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025009223A (en) | Clec9a binding agents and use thereof | |
| EA200601776A1 (en) | METADONIC COMPOSITIONS OF LOCAL ACTION AND METHODS OF THEIR APPLICATION | |
| JOP20200277B1 (en) | RIP1 inhibitors and methods for their preparation and use | |
| JOP20170135A1 (en) | Diazaspiroalkylmethyl-indoles | |
| WO2008129396A3 (en) | Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding | |
| MX339201B (en) | Sulphonamide compounds and methods of making and using same. | |
| MX343688B (en) | Tricyclic pyrazole sulfonamide compounds and methods of making and using same. | |
| MX2020004099A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same. | |
| UA105290C2 (en) | APTAMERS TO β-NGF AND THEIR USE IN TREATING β-NGF MEDIATED DISEASES AND DISORDERS | |
| ATE456369T1 (en) | FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES | |
| MX2009007784A (en) | Compositions of stable tiacumicins. | |
| NO20084826L (en) | New administration form of racecadotril | |
| WO2014141210A3 (en) | Multifunctional immature dental pulp stem cells and therapeutic applications | |
| WO2011026125A3 (en) | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen | |
| EA201291089A1 (en) | METHOD FOR OBTAINING PHARMACEUTICAL PREPARATIONS INTENDED FOR ORAL ADMINISTRATION, CONTAINING ONE OR MORE ACTIVE INGREDIENTS AND CONTAINING COMPOSITIONS | |
| JOP20210269A1 (en) | Aqueous pharmaceutical composition of an anti-il17a antibody and use thereof | |
| NZ708821A (en) | Lfa-1 inhibitor formulations | |
| MX2010009624A (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1. | |
| CY1116234T1 (en) | Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2 / 3 conformers | |
| WO2018033941A3 (en) | Pharmaceutical compositions of ibrutinib | |
| MX2012000954A (en) | Pharmaceutical compositions. | |
| TR200900879A2 (en) | Pharmaceutical compositions in which the active ingredients are combined in a single dosage form | |
| DE602004019528D1 (en) | COMPOSITIONS FOR TREATING RECURRENT APHTHS IN THE MOUTH VALVE | |
| CY1116158T1 (en) | Substituted 2-oxo- and 2-thiooxy-dihydroquinoline-3-carboxamides as KCNQ2 / 3 modulators | |
| EP2528440A4 (en) | SUBSTITUTED NORINDENOISOQUINOLEINS, THEIR SYNTHESIS AND METHODS OF USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |